1	Regulatory	regulatory	_	_	_	_	_	_	_
2	effects	effect	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	interleukin-11	interleukin-11	_	_	_	_	_	_	_
5	during	during	_	_	_	_	_	_	_
6	acute	acute	_	_	_	_	_	_	_
7	lung	lung	_	_	_	_	_	_	_
8	inflammatory	inflammatory	_	_	_	_	_	_	_
9	injury	injury	_	_	_	_	_	_	_
10	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	role	role	_	_	_	_	_	_	_
3	of	of	_	_	_	_	_	_	_
4	interleukin-11	interleukin-11	_	_	_	_	_	_	_
5	(	(	_	_	_	_	_	_	_
6	IL-11	IL-11	_	_	_	_	_	_	_
7	)	)	_	_	_	_	_	_	_
8	was	be	_	_	_	_	_	_	_
9	evaluated	evaluate	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	IgG	IgG	_	_	_	_	_	_	_
13	immune	immune	_	_	_	_	_	_	_
14	complex	complex	_	_	_	_	_	_	_
15	model	model	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	acute	acute	_	_	_	_	_	_	_
18	lung	lung	_	_	_	_	_	_	_
19	injury	injury	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	rats	rat	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	IL-11	IL-11	_	_	_	_	_	_	_
2	mRNA	mRNA	_	_	_	_	_	_	_
3	and	and	_	_	_	_	_	_	_
4	protein	protein	_	_	_	_	_	_	_
5	were	be	_	_	_	_	_	_	_
6	both	both	_	_	_	_	_	_	_
7	up-regulated	up-regulate	_	_	_	_	_	_	_
8	during	during	_	_	_	_	_	_	_
9	the	the	_	_	_	_	_	_	_
10	course	course	_	_	_	_	_	_	_
11	of	of	_	_	_	_	_	_	_
12	this	this	_	_	_	_	_	_	_
13	inflammatory	inflammatory	_	_	_	_	_	_	_
14	response	response	_	_	_	_	_	_	_
15	.	.	_	_	_	_	_	_	_

1	Exogenously	exogenously	_	_	_	_	_	_	_
2	administered	administer	_	_	_	_	_	_	_
3	IL-11	il-11	_	_	_	_	_	_	_
4	substantially	substantially	_	_	_	_	_	_	_
5	reduced	reduce	_	_	_	_	_	_	_
6	,	,	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	dose-dependent	dose-dependent	_	_	_	_	_	_	_
10	manner	manner	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	intrapulmonary	intrapulmonary	_	_	_	_	_	_	_
14	accumulation	accumulation	_	_	_	_	_	_	_
15	of	of	_	_	_	_	_	_	_
16	neutrophils	neutrophil	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	lung	lung	_	_	_	_	_	_	_
20	vascular	vascular	_	_	_	_	_	_	_
21	leak	leak	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	albumin	albumin	_	_	_	_	_	_	_
24	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	in	in	_	_	_	_	_	_	_
3	vivo	vivo	_	_	_	_	_	_	_
4	anti-inflammatory	anti-inflammatory	_	_	_	_	_	_	_
5	effects	effect	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	IL-11	IL-11	_	_	_	_	_	_	_
8	were	be	_	_	_	_	_	_	_
9	associated	associate	_	_	_	_	_	_	_
10	with	with	_	_	_	_	_	_	_
11	reduced	reduce	_	_	_	_	_	_	_
12	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
13	activation	activation	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	lung	lung	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	reduced	reduce	_	_	_	_	_	_	_
18	levels	level	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	tumor	tumor	_	_	_	_	_	_	_
21	necrosis	necrosis	_	_	_	_	_	_	_
22	factor	factor	_	_	_	_	_	_	_
23	alpha	alpha	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
26	)	)	_	_	_	_	_	_	_
27	in	in	_	_	_	_	_	_	_
28	bronchoalveolar	bronchoalveolar	_	_	_	_	_	_	_
29	lavage	lavage	_	_	_	_	_	_	_
30	(	(	_	_	_	_	_	_	_
31	BAL	BAL	_	_	_	_	_	_	_
32	)	)	_	_	_	_	_	_	_
33	fluids	fluid	_	_	_	_	_	_	_
34	,	,	_	_	_	_	_	_	_
35	and	and	_	_	_	_	_	_	_
36	diminished	diminish	_	_	_	_	_	_	_
37	up-regulation	up-regulation	_	_	_	_	_	_	_
38	of	of	_	_	_	_	_	_	_
39	lung	lung	_	_	_	_	_	_	_
40	vascular	vascular	_	_	_	_	_	_	_
41	ICAM-1	icam-1	_	_	_	_	_	_	_
42	.	.	_	_	_	_	_	_	_

1	It	it	_	_	_	_	_	_	_
2	is	be	_	_	_	_	_	_	_
3	interesting	interesting	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	IL-11	IL-11	_	_	_	_	_	_	_
6	did	do	_	_	_	_	_	_	_
7	not	not	_	_	_	_	_	_	_
8	affect	affect	_	_	_	_	_	_	_
9	BAL	bal	_	_	_	_	_	_	_
10	fluid	fluid	_	_	_	_	_	_	_
11	content	content	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	CXC	CXC	_	_	_	_	_	_	_
15	chemokines	chemokine	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	macrophage	macrophage	_	_	_	_	_	_	_
18	inflammatory	inflammatory	_	_	_	_	_	_	_
19	protein-2	protein-2	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	MIP-2	mip-2	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	cytokine-inducible	cytokine-inducible	_	_	_	_	_	_	_
25	neutrophil	neutrophil	_	_	_	_	_	_	_
26	chemoattractant	chemoattractant	_	_	_	_	_	_	_
27	(	(	_	_	_	_	_	_	_
28	CINC	CINC	_	_	_	_	_	_	_
29	)	)	_	_	_	_	_	_	_
30	;	;	_	_	_	_	_	_	_
31	the	the	_	_	_	_	_	_	_
32	presence	presence	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	IL-11	IL-11	_	_	_	_	_	_	_
35	did	do	_	_	_	_	_	_	_
36	not	not	_	_	_	_	_	_	_
37	affect	affect	_	_	_	_	_	_	_
38	these	these	_	_	_	_	_	_	_
39	chemokines	chemokine	_	_	_	_	_	_	_
40	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	BAL	bal	_	_	_	_	_	_	_
4	content	content	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	C5a	C5a	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	reduced	reduce	_	_	_	_	_	_	_
9	by	by	_	_	_	_	_	_	_
10	IL-11	IL-11	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	indicate	indicate	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	IL-11	il-11	_	_	_	_	_	_	_
6	is	be	_	_	_	_	_	_	_
7	a	a	_	_	_	_	_	_	_
8	regulatory	regulatory	_	_	_	_	_	_	_
9	cytokine	cytokine	_	_	_	_	_	_	_
10	in	in	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	lung	lung	_	_	_	_	_	_	_
13	and	and	_	_	_	_	_	_	_
14	that	that	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	like	like	_	_	_	_	_	_	_
17	other	other	_	_	_	_	_	_	_
18	members	member	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	this	this	_	_	_	_	_	_	_
21	family	family	_	_	_	_	_	_	_
22	,	,	_	_	_	_	_	_	_
23	its	its	_	_	_	_	_	_	_
24	anti-inflammatory	anti-inflammatory	_	_	_	_	_	_	_
25	properties	property	_	_	_	_	_	_	_
26	appear	appear	_	_	_	_	_	_	_
27	to	to	_	_	_	_	_	_	_
28	be	be	_	_	_	_	_	_	_
29	linked	link	_	_	_	_	_	_	_
30	to	to	_	_	_	_	_	_	_
31	its	its	_	_	_	_	_	_	_
32	suppression	suppression	_	_	_	_	_	_	_
33	of	of	_	_	_	_	_	_	_
34	NF-kappaB	NF-kappaB	_	_	_	_	_	_	_
35	activation	activation	_	_	_	_	_	_	_
36	,	,	_	_	_	_	_	_	_
37	diminished	diminish	_	_	_	_	_	_	_
38	production	production	_	_	_	_	_	_	_
39	of	of	_	_	_	_	_	_	_
40	TNF-alpha	TNF-alpha	_	_	_	_	_	_	_
41	,	,	_	_	_	_	_	_	_
42	and	and	_	_	_	_	_	_	_
43	reduced	reduce	_	_	_	_	_	_	_
44	up-regulation	up-regulation	_	_	_	_	_	_	_
45	of	of	_	_	_	_	_	_	_
46	lung	lung	_	_	_	_	_	_	_
47	vascular	vascular	_	_	_	_	_	_	_
48	ICAM-1	icam-1	_	_	_	_	_	_	_
49	.	.	_	_	_	_	_	_	_

